APA (7th ed.) Citation

Anker, S. D., Friede, T., von Bardeleben, R. S., Butler, J., Khan, M. S., Diek, M., . . . Kuck, K. (2024). Percutaneous repair of moderate‐to‐severe or severe functional mitral regurgitation in patients with symptomatic heart failure: Baseline characteristics of patients in the RESHAPE‐HF2 trial and comparison to COAPT and MITRA‐FR trials. European Journal of Heart Failure, 26(7), 1608. https://doi.org/10.1002/ejhf.3286

Chicago Style (17th ed.) Citation

Anker, Stefan D., et al. "Percutaneous Repair of Moderate‐to‐severe or Severe Functional Mitral Regurgitation in Patients with Symptomatic Heart Failure: Baseline Characteristics of Patients in the RESHAPE‐HF2 Trial and Comparison to COAPT and MITRA‐FR Trials." European Journal of Heart Failure 26, no. 7 (2024): 1608. https://doi.org/10.1002/ejhf.3286.

MLA (9th ed.) Citation

Anker, Stefan D., et al. "Percutaneous Repair of Moderate‐to‐severe or Severe Functional Mitral Regurgitation in Patients with Symptomatic Heart Failure: Baseline Characteristics of Patients in the RESHAPE‐HF2 Trial and Comparison to COAPT and MITRA‐FR Trials." European Journal of Heart Failure, vol. 26, no. 7, 2024, p. 1608, https://doi.org/10.1002/ejhf.3286.